Published in JAMA Psychiatry · View the paper (DOI)
A randomized, placebo-controlled trial confirms that Ozempic reduces alcohol craving, drinking quantity and the frequency of heavy drinking days. The study found that nearly 40% of people treated with semaglutide reported no heavy drinking days in the last month of treatment.
Coverage from 2 institutions